Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/16/2863846/0/en/Psyence-Group-s-NASDAQ-Listed-Associate-Psyence-Biomedical-Partners-with-Fluence-and-iNGEN%C5%AB-CRO-to-Train-Research-Therapists-for-Phase-IIb-Psilocybin-Trial.html
https://www.globenewswire.com/news-release/2024/03/18/2848159/0/en/Psyence-Biomedical-Welcomes-Results-of-a-Recent-Study-Highlighting-Benefits-of-Nature-Derived-Psilocybin-Vs-Synthetic-Psilocybin.html
https://www.globenewswire.com//news-release/2024/03/15/2847314/0/en/Psyence-Biomedical-Ltd-Receives-Nasdaq-Notifications-Regarding-Market-Value-of-Listed-Securities-and-Market-Value-of-Publicly-Held-Shares.html
https://www.globenewswire.com//news-release/2024/03/12/2844744/0/en/Psyence-Group-s-NASDAQ-Listed-Associate-Psyence-Biomedical-Receives-Human-Research-Ethics-Committee-HREC-Approval-to-Initiate-Phase-IIb-Study.html
https://www.globenewswire.com//news-release/2024/03/12/2844378/0/en/Psyence-Biomedical-Ltd-Issues-Shareholder-Letter-Recapping-Recent-Progress-and-Outlining-Key-Future-Milestones.html
https://www.globenewswire.com//news-release/2024/01/25/2817465/0/en/Psyence-Biomedical-Ltd-Approved-to-List-on-Nasdaq-following-Completion-of-Business-Combination-Agreement-with-Newcourt-Acquisition-Corp.html
https://www.globenewswire.com//news-release/2024/01/16/2809789/0/en/Psyence-Group-Inc-Subsidiary-Psyence-Biomedical-Ltd-announces-signing-of-definitive-agreement-for-a-convertible-note-in-connection-with-planned-business-combination.html
https://www.globenewswire.com//news-release/2023/10/30/2769460/0/en/Psyence-Production-Expands-Capability.html
https://www.globenewswire.com//news-release/2023/08/21/2728988/0/en/Psyence-Group-Announces-Closing-of-Private-Placement-Conclusion-of-Loan-Agreement.html
https://www.globenewswire.com/news-release/2023/08/02/2717053/0/en/Psyence-Group-Announces-SEC-Registration-Filing-with-NASDAQ-SPAC-Newcourt-and-Signing-of-Amended-and-Restated-Business-Combination-Agreement.html